Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome

(2010) Iusta Caminha et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

FAS-L, IL-10, and double-negative CD4-CD8- TCR  / + T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function

(2009) A. Magerus-Chatinet et al.   BLOOD

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome

(2009) David T. Teachey et al.   BRITISH JOURNAL OF HAEMATOLOGY

Membrane-bound Fas ligand only is essential for Fas-induced apoptosis

(2009) Lorraine A. O’ Reilly et al.   NATURE

Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

(2009) Prateek Kumar et al.   Nature Protocols

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)

(2009) V. Koneti Rao et al.   PEDIATRIC BLOOD & CANCER